340|1885|Public
50|$|Knockout mice {{deficient}} in either p40 or p19, or in either subunit of the IL-23 receptor (IL-23R and IL12R-β1) develop less severe symptoms of experimental autoimmune encephalomyelitis (EAE) and {{inflammatory bowel disease}} highlighting the importance of IL-23 in the <b>inflammatory</b> <b>pathway.</b>|$|E
50|$|KLF4 may promote {{inflammation}} by mediating NF-κB-dependent <b>inflammatory</b> <b>pathway</b> {{such as in}} macrophages, esophageal epithelium and in chemically-induced acute colitis in mice. However, KLF4 {{may also}} suppress the activation of inflammatory signaling such as in endothelial cells in response to pro-inflammatory stimuli.|$|E
50|$|Recently the {{responsible}} gene {{has been identified}} on Chromosome 15. Two mutations {{have been found in}} a protein called CD2 binding protein 1 (CD2BP1).This protein is part of an <b>inflammatory</b> <b>pathway</b> associated with other autoinflammatory diseases such as familial Mediterranean fever, Hyperimmunoglobulinemia D with recurrent fever, Muckle-Wells syndrome, neonatal onset multisystem inflammatory disease, and familial cold urticaria.|$|E
50|$|Rosiglitazone {{also appears}} to have an {{anti-inflammatory}} effect {{in addition to its}} effect on insulin resistance. Nuclear factor kappa-B (NF-κB), a signaling molecule, stimulates the <b>inflammatory</b> <b>pathways.</b> NF-κB inhibitor (IκB) downregulates the <b>inflammatory</b> <b>pathways.</b> When patients take rosiglitazone, NF-κB levels fall and IκB levels increase.|$|R
30|$|Introduction In recent studies, β 1 -adrenergic blocker {{demonstrated}} cardiovascular {{protection in}} sepsis. Experimental research showed that these benefits {{are associated with}} a down-regulation of <b>inflammatory</b> <b>pathways.</b> However, the specific impact of heart rate reduction on the <b>inflammatory</b> <b>pathways</b> remains unknown. Ivabradine is a pure heart rate-lowering drug that acts specifically on the sinoatrial node by selectively inhibiting the If current. The present study was designed to assess the effects of heart rate reduction by ivabradine on cardiovascular function and on the <b>inflammatory</b> <b>pathways</b> involved in peritonitis-induced septic rats.|$|R
40|$|In {{the last}} decades {{convergent}} findings from several lines of evidence has revealed a robust association between major depressive disorder (MDD) and <b>inflammatory</b> <b>pathways.</b> Despite this, the translation of these findings into new and better treatments for MDD has not occurred. {{the objective of this}} study is to comprehensively review what is already known with reasonable certainty on <b>inflammatory</b> <b>pathways</b> in MDD, to clarify some points that have been insufficiently studied and to discuss the implications of these findings for future studies targeting <b>inflammatory</b> <b>pathways</b> as a therapeutic tool for individuals with MDD. (C) 2014 S. Karger AG, Base...|$|R
5000|$|A recent (2010) {{study of}} the {{treatment}} of migraine with CGRP blockers shows promise. [...] In early trials, the first oral nonpeptide CGRP antagonist, MK-0974 (Telcagepant), was shown effective {{in the treatment of}} migraine attacks, but elevated liver enzymes in two participants were found. Other therapies and other links in the neurogenic <b>inflammatory</b> <b>pathway</b> for interruption of disease are under study, including migraine therapies.|$|E
50|$|Myelitis occurs due {{to various}} reasons such as {{infection}}s. Direct infection by viruses, bacteria, mold, or parasites such as {{human immunodeficiency virus}} (HIV), human T-lymphotropic virus types I and II (HTLV-I/II), syphilis, lyme disease, and tuberculosis can cause myelitis {{but it can also}} be caused due to non-infectious or <b>inflammatory</b> <b>pathway.</b> Myelitis often follows after the infections or after vaccination. These phenomena can be explained by a theory of autoimmune attack which states that the autoimmune bodies attack its spinal cord in response to immune reaction.|$|E
5000|$|The {{cascade of}} events in the <b>inflammatory</b> <b>pathway</b> that result from cell {{membrane}} disruption is well documented. [...] The release of membrane phospholipids leads to increased production of arachidonic acid which in turn results in elevated leukotriene, prostaglandin and thromboxane production. The ingredients in Azerizin are known to inhibit each of these three major paths of inflammation by blocking or down-regulating pro-inflammatory catalysts at multiple points in the inflammatory cascade, e.g., inhibition of phospholipase, lipooxygenase, COX-2, leukotrienes, thromboxane, prostaglandins, nitric oxide, monocyte chemoattractant protein-1 (MCP-1), tumor necrosis factor (TNF) and interleukin-12.|$|E
40|$|Inflammation {{involves}} alterations to vascular and immune cell function. It is well recognised {{that many}} physiological reproductive {{events such as}} ovulation, menstruation, implantation and onset of labour display hallmark signs of inflammation. These are orchestrated by specific molecular pathways involving a host of growth factors, cytokines, chemokines and lipid mediators. Resumption of normal reproductive function involves prompt and proper resolution of these <b>inflammatory</b> <b>pathways.</b> Recent literature confirms that resolution of <b>inflammatory</b> <b>pathways</b> involves specific biochemical events which are activated to re-establish homeostasis in the affected tissue. Moreover, initiation and maintenance of <b>inflammatory</b> <b>pathways</b> are key components of many pathologies of the reproductive tract {{and elsewhere in the}} body. The onset of reproductive disorders or disease {{may be the result of}} exacerbated activation and maintenance of <b>inflammatory</b> <b>pathways</b> or its dysregulated resolution. This review will address the role of inflammatory events in normal reproductive function and its pathologies...|$|R
40|$|Abstract Immune and <b>inflammatory</b> <b>pathways</b> have {{a central}} role in the {{pathogenesis}} of non-alcoholic fatty liver disease (NAFLD). Both the innate and adaptive immune systems contribute to the development of NAFLD. Patho-gen-associated molecular patterns and danger-associated molecular patterns are known to activate a variety of pat-tern-recognition receptors that result in inflammation. The key features of the immune system and <b>inflammatory</b> <b>pathways</b> in the development of NAFLD are discussed in this review...|$|R
30|$|Conclusion In {{experimental}} septic shock, low {{doses of}} Esmolol, still improved cardiac function and vasoreactivity. These benefits {{appear to be}} associated with a modulation of <b>inflammatory</b> <b>pathways.</b>|$|R
5000|$|Several {{monoclonal}} antibodies target cytokines, {{the molecules}} that cells use to send inflammatory signals to each other. TNF-α {{is one of}} the main executor inflammatory cytokines. Four monoclonal antibodies (MAbs) (infliximab, adalimumab, golimumab, and certolizumab pegol) and one recombinant TNF-α decoy receptor, etanercept, have been developed to inhibit TNF-α signaling. Additional monoclonal antibodies, such as ixekizumab, have been developed against pro-inflammatory cytokines and inhibit the <b>inflammatory</b> <b>pathway</b> at a different point than the anti-TNF-α antibodies. [...] IL-12 and IL-23 share a common domain, p40, which is the target of the recently FDA-approved ustekinumab. In 2017 the US FDA approved guselkumab for plaque psoriasis.|$|E
50|$|Acquired non-inflammatory {{myopathy}} (ANIM) is {{a neurological}} disorder primarily affecting skeletal muscle, most commonly in the limbs of humans, {{resulting in a}} weakness or dysfunction in the muscle. A myopathy refers to a problem or abnormality with the myofibrils, which compose muscle tissue. In general, non-inflammatory myopathies are a grouping of muscular diseases not induced by an autoimmune-mediated <b>inflammatory</b> <b>pathway.</b> These muscular diseases usually arise from a pathology within the muscle tissue itself rather than the nerves innervating that tissue. ANIM has {{a wide spectrum of}} causes which include drugs and toxins, nutritional imbalances, acquired metabolic dysfunctions such as an acquired defect in protein structure, and infections.|$|E
50|$|Nogo-A {{is a type}} of neurite growth {{inhibitory}} {{component that}} is present in the central nervous system myelin membranes (found in an axon). It has a crucial role in restricting axonal regeneration in adult mammalian central nervous system. In recent studies, if Nogo- A is blocked and neutralized, it is possible to induce long-distance axonal regeneration which leads to enhancement of functional recovery in rats and mouse spinal cord. This has yet to be done on humans. A recent study has also found that macrophages activated through a specific <b>inflammatory</b> <b>pathway</b> activated by the Dectin-1 receptor are capable of promoting axon recovery, also however causing neurotoxicity in the neuron.|$|E
5000|$|Acetylcysteine: It targets {{a diverse}} array of factors germane to the {{pathophysiology}} of multiple neuropsychiatric disorders including glutamatergic transmission, the antioxidant glutathione, neurotrophins, apoptosis, mitochondrial function, and <b>inflammatory</b> <b>pathways.</b>|$|R
50|$|The {{depletion}} of anticoagulant and anti-inflammatory proteins, in particular, protein C and its co-factor, protein S, may also promote thrombus formation, inhibit fibrinolysis {{and lead to}} further activation of the <b>inflammatory</b> <b>pathways.</b>|$|R
50|$|Anaphylatoxins {{are small}} {{complement}} peptides that induce proinflammatory responses in tissues. C3a is primarily regarded for {{its role in}} the innate and adaptive immune responses as an anaphylatoxin, moderating and activating multiple <b>inflammatory</b> <b>pathways.</b>|$|R
50|$|A {{polymorphism}} interaction analysis (PIA) algorithm {{was used}} to obtain cooperating single nucleotide polymorphisms (SNPs) that contribute to RA disease. The acquired SNP pairs were used to construct a SNP-SNP network. Sub-networks defined by hub SNPs were then extracted and turned into gene modules by mapping SNPs to genes using dbSNP database. The FESD Version II {{would also be a}} good choice in database because it also covers the dbSNP database. They ran the Haseman Elston test, then a random forest algorithm. The shared SNPs detected were then ran through a polymorphism interaction analysis (PIA) algorithm. They performed Gene ontology analysis of the 5 modules that were created. They suggested that Ets-1 may be an important transcription factor in the cytokine-mediated <b>inflammatory</b> <b>pathway</b> and destructive cascade characteristic of RA. The ATP-binding cassette (ABC) transporter, ABCA1, was induced during differentiation of human monocytes into macrophages, and there was a dual regulatory function for ABCA1 in macrophage lipid metabolism and inflammation. Extracellular signals are transduced intracellularly via multiple pathways, resulting in alterations in the transcription and translation of specific proteins. Some of these signaling pathways result in the production of proteins, including cytokines and matrix metalloproteinases, which are implicated in the pathogenesis of RA. The zinc-finger protein 238 (ZNF238) is attached to zinc-finger proteins that can regulate the human immunodeficiency virus type 1. Hub gene CD160 is a potential RA association gene. The CD160 receptor represents a unique triggering surface molecule that is expressed by cytotoxic NK cells, it participates in the inflammatory response and determines the type of subsequent specific immunity.|$|E
40|$|Cancer-related {{inflammation}} {{recently has}} been proposed as a major physiological hallmark of malignancy. Some genetic alterations known to promote cellular proliferation and induce malignant transformation also may participate in an intrinsic <b>inflammatory</b> <b>pathway</b> that produces a cancer-promoting inflammatory microenvironment. Little is known about this intrinsic <b>inflammatory</b> <b>pathway</b> in Barrett's esophagus. We have used a series of nontransformed and transformed human Barrett's epithelial cell lines developed in our laboratory to explore the potential contribution of interleukin (IL) - 6 and signal transducer and activator of transcription (STAT 3) (key molecules in the intrinsic <b>inflammatory</b> <b>pathway)</b> to Barrett's carcinogenesis. We determined IL- 6 mRNA expression and protein secretion and protein expression of activated phospho-STAT 3 and its downstream target myeloid cell leukemia (mcl) - 1 (Mcl- 1). We used an IL- 6 blocking antibody and two JAK kinase inhibitors (AG 490 and JAK inhibitor I) to assess whether STAT 3 activation is IL- 6 dependent. We also used small interfering RNAs (siRNAs) to STAT 3 and Mcl- 1 to assess effects of STAT 3 pathway inhibition on apoptosis. Phospho-STAT 3 was expressed only by transformed Barrett's cells, which also exhibited higher levels of IL- 6 mRNA and of IL- 6 and Mcl- 1 proteins than nontransformed Barrett's cells. STAT 3 phosphorylation could be blocked by IL- 6 blocking antibody and by AG 490 and JAK inhibitor I. In transformed Barrett's cells, rates of apoptosis following exposure to deoxycholic acid were significantly increased by transfection with siRNAs for STAT 3 and Mcl- 1. We conclude that activation of the IL- 6 /STAT 3 pathway in transformed Barrett's epithelial cells enables them to resist apoptosis. These findings demonstrate a possible contribution of the intrinsic <b>inflammatory</b> <b>pathway</b> to carcinogenesis in Barrett's esophagus...|$|E
40|$|Severe {{infection}} induces both {{activation of}} the coagulation system and multiple other inflammatory mediator cascades. This concise review summarizes the current knowledge of mechanisms that are considered {{to contribute to the}} procoagulant response to sepsis. Furthermore, evidence is discussed that mediators traditionally involved in the regulation of the hemostatic balance may also influence other <b>inflammatory</b> <b>pathway...</b>|$|E
50|$|GSEA {{can help}} provide {{molecular}} {{evidence for the}} association of biological pathways with diseases. Previous studies shown that long-term depression symptoms are correlated with changes in immune response and <b>inflammatory</b> <b>pathways.</b> A study by Elovainio et al. was aimed at finding genetic and molecular evidence that supports this association. The researchers took blood samples from the Young Finns Study (participants were depression patients), and used genome-wide expression data, along with GSEA to find expression differences in gene sets related to <b>inflammatory</b> <b>pathways.</b> The study found that patients who rated with the most severe depression symptoms also had significant expression differences in those gene sets, and this result supports the association hypothesis.|$|R
50|$|Reverse {{migration}} is the phenomena {{in which some}} neutrophils migrate away from the inflammation site, against the chemokine gradient, during inflammation resolution. The activation of in vivo <b>inflammatory</b> <b>pathways</b> (such as hypoxia-inducible factor, HIF), altered this behavior of reverse migration.|$|R
40|$|Type 1 {{diabetes}} (T 1 D) {{has been}} associated with both genetic and environmental factors. Increasing incidence of T 1 D worldwide is prompting researchers to adopt different approaches to explain the biology of T 1 D, beyond the presence and activity of autoreactive lymphocytes. In this review, we propose <b>inflammatory</b> <b>pathways</b> as triggers for T 1 D. Within the scope of those <b>inflammatory</b> <b>pathways</b> and in understanding the pathogenesis of disease, we suggest that viruses, in particular Coxsackieviruses, act by causing a type 1 interferonopathy within the pancreas and the microenvironment of the islet. As such, this connection and common thread represents an exciting platform for the development of new diagnostic, treatment and/or prevention options...|$|R
40|$|Includes abstract. Includes bibliographical {{references}} (leaves 159 - 179). The aims of this dissertation {{were therefore}} (i) {{to follow a}} pathway-based approach investigating genes encoding proteins involved in the ECM degradation and apoptosis signalling cascade for associations with AT and (ii) to identify a polygenic risk model, comprised of several genetic markers within genes encoding proteins involved in the <b>inflammatory</b> <b>pathway,</b> to predict risk of AT...|$|E
40|$|Our {{aim was to}} {{investigate}} whether celecoxib, a cyclooxygenase 2 (COX- 2) inhibitor, decreases the in vitro proliferation of leiomyoma cells if the <b>inflammatory</b> <b>pathway</b> is blocked. Menstruation is an inflammation of uterus that produces cytokines and prostanoids, but the inflammatory mechanism underlying the growth of leiomyoma remains unexplained. Using in vitro cultures of leiomyoma cells obtained from 5 patients who underwent hysterectomy, cell proliferation, inflammatory signaling, transcription factors, growth factors, and extracellular matrix were examined by (4, 5 -dimethylthiaxol- 2 -yi) - 2, 5 -diphenyltetraxolium bromide assay, immunoblotting, and quantitative polymerase chain reaction. Prostaglandin E 2 was used to induce menstruation-like con-dition in the cells. We found that celecoxib inhibited COX- 2 through the expression of nuclear factor kB in the cells. Celcoxib also decreased the gene expression of interleukin 6, tumor necrosis factor a, collagen A, fibronectin, platelet-derived growth fac-tor, epidermal growth factor, and transforming growth factor b. In conclusion, the present study indicated that celecoxib could inhibit leiomyoma cell proliferation through blocking the <b>inflammatory</b> <b>pathway</b> that {{is probably one of}} the mechanisms underlying its pathogenesis...|$|E
40|$|Objective: To {{investigate}} {{the effect of}} different blood glucose levels on viscera injury, oxidative stress response and Wnt 5 a <b>inflammatory</b> <b>pathway</b> in children with sepsis. Methods: 70 children with sepsis treated in our hospital between January 2014 and December 2015 were retrospectively collected and divided into the sepsis group A (blood glucose ＞ 10 mmol/L) (n= 29) and the sepsis group B (blood glucose ≤ 10 mmol/L) (n= 41) according to the different blood glucose levels, and 50 healthy children who accepted vaccination and were with normal blood glucose levels in our hospital {{during the same period}} were selected as healthy control group. The day after admission, RIA method was used to determine liver function indexes; automatic biochemical analyzer was used to determine oxidative stress indexes; enzymelinked immunosorbent assay (ELISA) was used to detect Wnt 5 a <b>inflammatory</b> <b>pathway</b> index levels. Results: Liver function indexes total bilirubin (TBIL), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels of sepsis group A were higher than those of sepsis group B and healthy control group (P< 0. 05); oxidative stress indexes advanced protein oxidation products (AOPPs), lipid hydrogen peroxide (LHP), reactive oxygen species (ROS), and malondialdehyde (MDA) levels were higher than those of sepsis group B and healthy control group while glutathione peroxidase (GSH-Px) level was lower than that of sepsis group B and healthy control group (P< 0. 05); serum Wnt 5 a <b>inflammatory</b> <b>pathway</b> indexes interleukin- 1 β (IL- 1 β), interleukin- 6 (IL- 6), interleukin- 12 (IL- 12) and macrophage inflammatory protein- 1 β (MIP- 1 β) levels were higher than those of sepsis group B and healthy control group (P< 0. 05). Conclusions: Sepsis children with high blood glucose are with severe liver function damage as well as intense oxidative stress and inflammatory response, which are the important indexes for severe illness and poor prognosis...|$|E
40|$|Background. Maternal obesity, {{excess weight}} gain and overnutrition during {{pregnancy}} increase risks of obesity, {{type 2 diabetes}} mellitus, and cardiovascular disease in the offspring. Maternal biliopancreatic diversion is an effective treatment for severe obesity and is beneficial for offspring born after maternal surgery (AMS). These offspring exhibit lower severe obesity prevalence and improved cardiometabolic risk factors including inflammatory marker compared to siblings born before maternal surgery (BMS). Objective. To assess relationships between maternal bariatric surgery and the methylation/expression of genes involved in the immune and <b>inflammatory</b> <b>pathways.</b> Methods. A differential gene methylation analysis was conducted in a sibling cohort of 25 BMS and 25 AMS offspring from 20 mothers. Following differential gene expression analysis (23 BMS and 23 AMS), pathway analysis was conducted. Correlations between gene methylation/expression and circulating inflammatory markers were computed. Results. Five immune and <b>inflammatory</b> <b>pathways</b> with significant overrepresentation of both differential gene methylation and expression were identified. In the IL- 8 pathway, gene methylation correlated with both gene expression and plasma C-reactive protein levels. Conclusion. These results suggest that improvements in cardiometabolic risk markers in AMS compared to BMS offspring may be mediated through differential methylation of genes involved in immune and <b>inflammatory</b> <b>pathways...</b>|$|R
40|$|Cervical {{cancer is}} one of the leading gynaecological {{malignancies}} worldwide. It is an infectious disease of the cervix, associated with human papillomavirus infection (HPV), infection with bacterial agents such as Chlamydia trachomatis and Neisseria gonorrhoea as well as human immunodeficiency virus (HIV). Furthermore, it is an AIDS-defining disease with an accelerated mortality in HIV-infected women with cervical cancer. With the introduction of robust vaccination strategies against HPV in the developed world, it is anticipated that the incidence of cervical cancer will decrease in the coming years. However, vaccination has limited benefit for women already infected with high-risk HPV, and alternative therapeutic intervention strategies are needed for these women. Many pathological disorders, including cervical cancer, are characterised by the exacerbated activation and maintenance of <b>inflammatory</b> <b>pathways</b> which are considered to be regulated by infectious agents. In cervical cancer, hyperactivation of these <b>inflammatory</b> <b>pathways</b> and regulation of immune infiltrate into tissues can potentially play a role not only in tumorigenesis but also in HIV infection. In this paper we will discuss the contribution of <b>inflammatory</b> <b>pathways</b> to cervical cancer progression and HIV infection and the role of HIV in cervical cancer progression...|$|R
40|$|Obese {{pregnant}} women have {{increased levels of}} proinflam-matory cytokines in maternal circulation and placental tissues. However, the pathways contributing to placental inflammation in obesity are largely unknown. We tested the hypothesis that maternal body mass index (BMI) was associated with elevated proinflammatory cytokines in maternal and fetal circulations and increased activation of placental <b>inflammatory</b> <b>pathways.</b> A total of 60 women of varying pre-/early pregnancy BMI, undergoing delivery by Cesarean section at term, were studied. Maternal and fetal (cord) plasma were collected for analysis of insulin, leptin, IL- 1 beta, IL- 6, IL- 8, monocyte chemoattractant protein (MCP) 1, and TNFalpha by multiplex ELISA. Activation of the <b>inflammatory</b> <b>pathways</b> in the placenta was investigated by measuring the phosphorylated and total protein expression o...|$|R
40|$|Objective. The aim of {{this study}} was to {{investigate}} the effect of CAPE on the insulin signaling and <b>inflammatory</b> <b>pathway</b> in the liver of mice with high fat diet induced obesity. Material/Methods. Swiss mice were fed with standard chow or high-fat diet for 12 -week. After the eighth week, animals in the HFD group with serum glucose levels higher than 200 mg/dL were divided into two groups, HFD and HFD receiving 30 mg/kg of CAPE for 4 weeks. After 12 weeks, the blood samples could be collected and liver tissue extracted for hormonal and biochemical measurements, and insulin signaling and <b>inflammatory</b> <b>pathway</b> analyzes. Results. The high-fat diet group exhibited more weight gain, glucose intolerance, and hepatic steatosis compared with standard diet group. The CAPE treatment showed improvement in glucose sensitivity characterized by an area under glucose curve similar to the control group in an oral glucose tolerance test Furthermore, CAPE treatment promoted amelioration in hepatic steatosis compared with the high-fat diet group. The increase in glucose sensitivity was associated with the improvement in insulin-stimulated phosphorylation of the insulin receptor substrate- 2, followed by an increase in Akt phosphorylation. In addition, it was observed that CAPE reduced the induction of the <b>inflammatory</b> <b>pathway,</b> c-jun-N- terminal kinase, the nuclear factor kappa B, and cyclooxygenase- 2 expression, respectively. Conclusions. Overall, these findings indicate that CAPE exhibited anti-inflammatory activity that partly restores normal metabolism, reduces the molecular changes observed in obesity and insulin resistance, and therefore has a potential as a therapeutic agent in obesity. (C) 2012 Elsevier Inc. All rights reserved. Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [04 / 13981 - 0, 05 / 57848 - 5...|$|E
40|$|This is {{the final}} version of the article. Available from the {{publisher}} via the DOI in this record. BACKGROUND: Since mediators of inflammation are associated with insulin resistance, and the risk of developing diabetes mellitus and gestational diabetes, we hypothesized that genetic variation in members of the inflammatory gene pathway impact glucose levels and related phenotypes in pregnancy. We evaluated this hypothesis by testing for association between genetic variants in 31 <b>inflammatory</b> <b>pathway</b> genes in the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) cohort, a large multiethnic multicenter study designed to address the impact of glycemia less than overt diabetes on pregnancy outcome. RESULTS: Fasting, 1 -hour, and 2 -hour glucose, fasting and 1 -hour C-peptide, and HbA 1 c levels were measured in blood samples obtained from HAPO participants during an oral glucose tolerance test at 24 - 32 weeks gestation. We tested for association between 458 SNPs mapping to 31 genes in the <b>inflammatory</b> <b>pathway</b> and metabolic phenotypes in 3836 European ancestry and 1713 Thai pregnant women. The strongest evidence for association was observed with TNF alpha and HbA 1 c (rs 1052248; 0. 04...|$|E
30|$|Immobilization and inflammation—rather than {{inadequate}} nutritional support—might {{be major}} determinants {{of loss of}} muscle. Inactivity is a potent stimulus to muscle protein breakdown and activation of the ubiquitin–proteasome pathway of proteolysis [48]. Immobility of limbs is quite common in ICU patients and is related to bed rest and sedation. Acute and chronic activation of <b>inflammatory</b> <b>pathway</b> is another potent stimulus for proteolysis [49]. Though, in our study we did not measure any index of inflammatory activity and we could not verify such contention.|$|E
40|$|Accumulating {{evidence}} indicates an important pathophysiological role of brain inflammation in epilepsy. In this review, {{we will provide}} an update of specific <b>inflammatory</b> <b>pathways</b> that have been proposed to be crucial in the underlying molecular mechanisms of epilepsy, including the interleukin- 1 receptor/toll-like receptor signaling, cyclooxygenase- 2, tumor necrosis factor-alpha, complement signaling and chemokines. Furthermore, by drawing on evidence from preclinical and clinical studies we will discuss the potential of these signaling pathways targets for novel therapeutic interventions that control drug-resistant seizures or have disease-modifying effects. Finally, we will assess {{the use of these}} <b>inflammatory</b> <b>pathways</b> as potential biomarkers for the development of epilepsy or to measure the effectiveness of therapeutic interventions. This article is protected by copyright. All rights reserve...|$|R
40|$|Abstract: Malignant Mesothelioma (MM) is an {{asbestos}} related malignancy with a {{poor prognosis}} and limited therapeutic approaches. The pathogenesis of MM {{has been linked}} to asbestos induced inflammation. Asbestos exposure results in reactive oxygen species generation, infiltration of inflammatory cells and prolonged release of multiple cytokines, oxidants and growth factors. The role of inflammation in MM has led to the evaluation of inflammatory profiles as prognostic and therapeutic markers. Additionally, <b>inflammatory</b> <b>pathways</b> are under investigation for potential therapeutic interventions. In this review, we discuss the role of inflammation in MM pathogenesis, inflammatory markers with potential clinical impact for MM and clinical trials that target <b>inflammatory</b> <b>pathways</b> and responses for treatment of MM. Ultimately, MM remains a difficult to treat cancer that requires multimodality therapy...|$|R
40|$|Prolonged {{activation}} of <b>inflammatory</b> <b>pathways</b> in the endothelium leads to vascular diseases, including sepsis and atherosclerosis. During this process, activated endothelial cells recruit circulating leukocytes by expressing adhesion molecules and chemoattractants, such as vascular cellular adhesion molcculc- 1 (VCAM- 1) and monocyte chemoattractant protein- 1 (MCP- 1) ...|$|R
